Reuters logo
BRIEF-Xencor's lead drug candidate receives orphan drug designation from FDA
2017年5月11日 / 下午12点33分 / 6 个月前

BRIEF-Xencor's lead drug candidate receives orphan drug designation from FDA

May 11 (Reuters) - Xencor Inc

* Xencor’s lead drug candidate, xmab5871, receives orphan drug designation from fda for treatment of igg4-related disease Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below